Indonesia · Delayed Price · Currency is IDR IDX:BMRI Statistics
Total Valuation
IDX:BMRI has a market cap or net worth of IDR 384.53 trillion.
| Market Cap | 384.53T |
| Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | May 11, 2026 |
Share Statistics
IDX:BMRI has 93.33 billion shares outstanding. The number of shares has decreased by -0.06% in one year.
| Current Share Class | 93.33B |
| Shares Outstanding | 93.33B |
| Shares Change (YoY) | -0.06% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 14.82% |
| Float | 37.44B |
Valuation Ratios
The trailing PE ratio is 6.17 and the forward PE ratio is 6.95. IDX:BMRI's PEG ratio is 0.96.
| PE Ratio | 6.17 |
| Forward PE | 6.95 |
| PS Ratio | 2.68 |
| PB Ratio | 1.31 |
| P/TBV Ratio | 1.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.96 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.18 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 22.38%.
| Return on Equity (ROE) | 22.38% |
| Return on Assets (ROA) | 2.62% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 2.04% |
| Revenue Per Employee | 3.58B |
| Profits Per Employee | 1.55B |
| Employee Count | 40,101 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IDX:BMRI has paid 15.81 trillion in taxes.
| Income Tax | 15.81T |
| Effective Tax Rate | 19.30% |
Stock Price Statistics
The stock price has decreased by -11.78% in the last 52 weeks. The beta is -0.06, so IDX:BMRI's price volatility has been lower than the market average.
| Beta (5Y) | -0.06 |
| 52-Week Price Change | -11.78% |
| 50-Day Moving Average | 4,153.20 |
| 200-Day Moving Average | 4,600.28 |
| Relative Strength Index (RSI) | 45.52 |
| Average Volume (20 Days) | 152,240,605 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:BMRI had revenue of IDR 143.51 trillion and earned 62.25 trillion in profits. Earnings per share was 667.40.
| Revenue | 143.51T |
| Gross Profit | 140.95T |
| Operating Income | 81.94T |
| Pretax Income | 81.94T |
| Net Income | 62.25T |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 667.40 |
Balance Sheet
The company has 207.94 trillion in cash and 351.98 trillion in debt, with a net cash position of -144,042.34 billion or -1,543.31 per share.
| Cash & Cash Equivalents | 207.94T |
| Total Debt | 351.98T |
| Net Cash | -144,042.34B |
| Net Cash Per Share | -1,543.31 |
| Equity (Book Value) | 293.02T |
| Book Value Per Share | 3,049.22 |
| Working Capital | -1,606,481.17B |
Cash Flow
In the last 12 months, operating cash flow was -292,997.79 billion and capital expenditures -4,817.01 billion, giving a free cash flow of -297,814.80 billion.
| Operating Cash Flow | -292,997.79B |
| Capital Expenditures | -4,817.01B |
| Depreciation & Amortization | n/a |
| Net Borrowing | 47.73T |
| Free Cash Flow | -297,814.80B |
| FCF Per Share | -3,190.87 |
Margins
| Gross Margin | n/a |
| Operating Margin | 57.10% |
| Pretax Margin | 57.09% |
| Profit Margin | 43.38% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 476.96, which amounts to a dividend yield of 11.41%.
| Dividend Per Share | 476.96 |
| Dividend Yield | 11.41% |
| Dividend Growth (YoY) | 2.31% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 71.44% |
| Buyback Yield | 0.06% |
| Shareholder Yield | 11.31% |
| Earnings Yield | 16.19% |
| FCF Yield | -77.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for IDX:BMRI is 5,342.92, which is 29.68% higher than the current price. The consensus rating is "Buy".
| Price Target | 5,342.92 |
| Price Target Difference | 29.68% |
| Analyst Consensus | Buy |
| Analyst Count | 25 |
| Revenue Growth Forecast (3Y) | 3.90% |
| EPS Growth Forecast (3Y) | 5.25% |
Stock Splits
The last stock split was on April 4, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Apr 4, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |